SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000878088-12-000051
Filing Date
2012-08-02
Accepted
2012-08-02 16:10:16
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prx-6302012x10q.htm 10-Q 1979574
2 CEO CERTIFIICATION prx-6302012xex311.htm EX-31.1 13270
3 CFO CERTIFICATION prx-6302012xex312.htm EX-31.2 13274
4 CEO CERTIFICATION ATTACHED prx-6302012xex321.htm EX-32.1 5730
5 CFO CERTIFICATION ATTACHED prx-6302012xex322.htm EX-32.2 5411
  Complete submission text file 0000878088-12-000051.txt   13280509

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prx-20120630.xml EX-101.INS 2442595
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prx-20120630.xsd EX-101.SCH 83446
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prx-20120630_cal.xml EX-101.CAL 120505
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prx-20120630_def.xml EX-101.DEF 350633
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prx-20120630_lab.xml EX-101.LAB 842561
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prx-20120630_pre.xml EX-101.PRE 501001
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 121003559
SIC: 2834 Pharmaceutical Preparations